Design Therapeutics, Inc.
DSGN
$5.41
$0.214.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.72% | -29.77% | -4.69% | -10.57% | -6.20% |
| Total Depreciation and Amortization | -4.40% | 6.71% | -2.61% | 1.32% | 5.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.25% | 21.92% | 22.07% | -3.87% | 18.74% |
| Change in Net Operating Assets | 158.20% | -205.96% | -3.88% | 224.41% | 54.06% |
| Cash from Operations | 13.99% | -70.27% | -3.29% | 15.22% | 9.48% |
| Capital Expenditure | -20.83% | -- | -100.00% | 109.94% | 17.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 154.38% | 333.52% | 131.36% | -121.25% | 32.11% |
| Cash from Investing | 155.60% | 329.59% | 131.45% | -121.31% | 32.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,469.57% | -91.25% | 26,200.00% | -99.56% | 1,045.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,469.57% | -91.25% | 26,200.00% | -99.56% | 1,045.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.85% | -14.57% | 49.48% | -194.29% | 98.88% |